News

Photo

Shell Invests in Chemicals to Accelerate Zero Emissions Goal

Shell has announced plans to invest $4-5 billion annually to grow its chemicals and products business as part of an organizational restructuring that aims to accelerate the Anglo-Dutch group’s target of becoming a net-zero emissions energy business by 2050 or sooner.

Photo

CureVac Vaccine in EMA Rolling Review Process

German biotech CureVac has begun a rolling submission with the European Medicines Agency (EMA) for its mRNA-based Covid-19 vaccine candidate currently in Phase 2b/3 clinical trials with 35,000 people in Europe and Latin America.

Photo

Lanxess to Acquire Emerald Kalama Chemical

Germany’s Lanxess has signed a binding agreement to acquire 100% of Emerald Kalama Chemical from affiliates of private equity firm American Securities. The US specialty chemicals producer focused mainly on consumer markets last reported sales of $425 million and EBITDA pre-exceptionals of $90 million. Closing is expected in the second half of 2021, subject to regulatory approval.

Photo

BioNTech Starts mRNA Production in Marburg

BioNTech this week kicked off production at the Marburg, Germany, plant it acquired last year from Novartis. The plant will focus on making mRNA batches, the beginning of the manufacturing chain for the Covid-19 vaccine Comirnaty that BioNTech is producing and marketing together with US drugmaker Pfizer.

Photo

Honeywell Wins Egyptian Petchems Contract

Honeywell Process Solutions (HPS) has won a contract to upgrade Sidi Kerir Petrochemicals Company’s (Sidpec) production capabilities at its flagship complex in Alexandria, Egypt.

Photo

FDA Grants EUA for Lilly Antibody Cocktail

The US Food and Drug administration (FDA) has granted an Emergency Use Authorization (EUA) for the bamlanivimab-etesevimab antibody cocktail made by Eli Lilly for treatment of patients 12 and older who have mild to moderate cases of Covid-19 but are at risk of developing a severe form of the disease.

Photo

China’s WuXi Buys Bristol Myers Squibb’s Swiss Plant

China contract development and manufacturing organization (CDMO) WuXi STA has agreed to buy Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland, for an undisclosed sum. The site will be WuXi STA’s first facility in Europe. The transaction is expected to complete during the second quarter, subject to the usual conditions and regulatory approvals.

Photo

Clariant Finances Catalyst Research at ETH Zurich

Clariant has signed a cooperation agreement with the Swiss Federal Institute of Technology (ETH Zurich) to support research in catalysis and sustainable chemistry. It is providing the university with what it says is “a significant financial contribution” over an initial period of ten years. Terms were not disclosed.

Photo

Jazz Buys the UK’s GW Pharma

Ireland-based multinational drug company Jazz Pharmaceuticals is to buy UK biopharma GW Pharma for $7.2 billion, creating a leader in neuroscience. The boards of directors of both companies have unanimously approved the deal, which is expected to close in the second quarter, subject to customary conditions and regulatory approvals.

Photo

Pfizer and BionTech Aim to Cut Vaccine Production Time

Pfizer and BioNTech are accelerating the time it takes to produce a Covid-19 vaccine batch and are aiming to almost cut it in half, Chaz Calitri, vice president of sterile injectables at Pfizer, said in an interview with the US newspaper USA Today.

Photo

Nuberg Wins Egypt Sulfuric Acid Project

Indian engineering group Nuberg has been awarded a sulfuric acid project in Egypt. Chemicals and plastics manufacturer Sprea Misr has granted a lumpsum turnkey contract for the project’s engineering, procurement and construction services. The value of the contract was not disclosed.

Photo

Borealis Kicks off Sales Process for Nitrogen

Austrian chemical producer Borealis has announced plans to divest its nitrogen business, including fertilizer, technical nitrogen and melamine products. The Vienna-based group, which has increasingly shifted its focus to petrochemicals and plastics, has begun consultations with employee representatives.

Photo

AkzoNobel Walks Away from Tikkurila

AkzoNobel has conceded defeat in its bid to buy Tikkurila, leaving the way clear for US rival PPG Industries to continue with its acquisition of the Finnish paints and coatings company.

Photo

Germany’s Merck to Expand Lipid Supply to BioNTech

Expanding its supply relationship with compatriot BioNTech, Germany’s Merck said it will “significantly accelerate” the supply of urgently needed lipids to vaccine maker BionTech at Mainz and increase the volume of deliveries up to the end of 2021.

Photo

Wacker Chemie to Buy California CDMO Genopis

German chemical producer Wacker Chemie is acquiring 100% of San Diego, California- headquartered CDMO Genopis from its two South Korean owners, Helixmith and Medivate Partner, both based in Seoul.

Photo

India’s Eternis Acquires Tennants Fine Chemicals

Indian aroma chemicals producer Eternis has acquired the UK’s Tennants Fine Chemicals and its wholly owned subsidiaries in Singapore and Shanghai, China, for an undisclosed sum. The deal is Eternis’ first acquisition outside of India.

Photo

BASF again Named World’s Most Valuable Chemicals Brand

A coalescing of factors has led to arrested growth across the chemicals sector this year, with the brand value of the top 25 most valuable chemicals brands contracting by 8% on average, according to the latest report by Brand Finance, an independent brand valuation consultancy.

Photo

Novozymes and FMC Link on Biological Pest Control

Danish biotech Novozymes has announced a collaboration with US agricultural sciences group FMC to research, develop and commercialize biological enzyme-based crop protection solutions. The move is part of Novozymes’ entry into the biocontrol segment, using its new enzyme-based technology.

Photo

BASF Commissions Custom Rhine Tanker

To facilitate shipping on the Rhine River at extremely low water levels, BASF has commissioned a special tanker, which is currently being built by Stolt Tankers. Scheduled for delivery in late 2022, it will be operated exclusively for the German chemical group.

Photo

Azelis Takes Over Italy’s Came

Continuing its acquisition spree of recent weeks, Azelis is to take over Italy’s Came Chemical Mineral and Engineering for an undisclosed sum. Headquartered in Milan, Came specializes in distributing chemicals for friction and sintering applications, the coatings, adhesives, sealants and elastomers (CASE) segment and cosmetics.

Photo

DuPont Sells Clean Technologies to Consortium

DuPont has agreed to sell its Clean Technologies business for $510 million to an international private equity consortium, comprising BroadPeak Global, Asia Green Fund and The Saudi Arabian Industrial Investments Company (Dussur).

Photo

Johnson & Johnson’s Covid Vaccine 66% Effective

Johnson & Johnson's Covid-19 vaccine just emerging from Phase 3 clinical trials showed 66% efficacy in moderate to severe disease, and as much as to 85% in severe disease, the US healthcare group said in its first report on trial results.

Photo

India’s Grasim Industries to Enter Paints Market

The board of directors at Grasim Industries, part of Indian conglomerate Aditya Birla, has approved the company’s entry into the paints business. It has also given the go-ahead for an initial spend of 50 billion Indian rupees – equating to about $683 million – over the next three years to establish the business, which aims to become a “strong number two player” in the Indian decorative paints market.

Photo

ADNOC Boosts Downstream Investment Plans

Abu Dhabi National Oil Company (ADNOC) has merged its downstream unit with its trading arm, creating the Downstream Industry, Marketing & Trading Directorate. The company said the new unit will be a critical milestone toward its goal to responsibly deliver energy and energy products, particularly in its core Asian market, where it expects demand for refined and petrochemical products to grow over the next 10 years.

Photo

Bayer to also Manufacture CureVac Covid Shot

Vaccines and treatments for Covid-19 continue to dominate global pharma market headlines. As the pandemic drags on, new issues continuously arise, some of them discouraging, such as the emergence of more and more virus mutants or production glitches that threaten to curb supply.

Photo

And the Winners Are: Affix Labs, Caphenia, and Senorics

The CHEManager Innovation Pitch, CHEManager's start-up support initiative, entered its third year in January. But that wasn't the end of the 2020 cohort, as there were still the CHEManager Innovation Pitches of the Year to be selected. This took place at the end of January in a virtual jury session.

Photo

Brenntag Buys UK’s ICL Packed

Brenntag has strengthened its water treatment business in the UK with the acquisition of ICL Packed, its second purchase this year so far. Financial terms of the deal, which was signed and closed on the same day, were not disclosed.

Photo

EMA Greenlights AstraZeneca Covid Vaccine

As expected, the Europe Medicines Agency (EMA) on Jan. 29 gave the green light for AstraZeneca’s Covid-19 vaccine for use in the Covid-19 vaccine for use in the 27-member EU. Rather than this news, however, the political fallout over the bloc’s response to the drugmaker’s delivery delays announced at the beginning of the week continued to dominate the conversation.

Photo

Shintech Hikes PVC Capacity Again in Louisiana

Shintech, the US arm of Japan’s Shin-Etsu Chemical and the world’s largest producer of PVC, has announced a further vinyls expansion in Louisiana, as it continues work on another PVC project in the same state.

Photo

Brenntag to Buy Food Ingredients Distributor in China

In a move to expand its food and nutrition business in China, Germany-based international distributor Brenntag said it plans to acquire the majority of specialty ingredients distributor Zhongbai Xingye. The activities will become part of the global division of Brenntag Specialties. The deal values the business at about €90 million.

Photo

Novartis Offers EU Help on Vaccine Supply Front

With news of an EU Covid-19 vaccine shortage dominating international headlines, another European player is stepping up to try to bridge the gap. On the heels of French drugmaker Sanofi, Swiss pharma giant Novartis said this week it is exploring whether it can deploy its own manufacturing network to boost supply.

10877 more News

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.